| Brand | Active ingredient | Application holder | Expiry | Excl. |
|---|---|---|---|---|
| ABILIFY MAINTENA KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 08 Mar | - |
| ABILIFY MAINTENA KIT | ARIPIPRAZOLE | OTSUKA PHARMACEUTICAL CO LTD | 06 Apr | - |
| ABRAXANE | PACLITAXEL | BRISTOL-MYERS SQUIBB CO | 12 Jan | - |
| ABRAXANE | PACLITAXEL | BRISTOL-MYERS SQUIBB CO | 12 Jul | - |
| ADEMPAS | RIOCIGUAT | BAYER HEALTHCARE PHARMACEUTICALS INC | 18 Feb | - |
| AIRDUO DIGIHALER | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 06 Oct | - |
| AIRDUO RESPICLICK | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 06 Oct | - |
| ALKINDI SPRINKLE | HYDROCORTISONE | ETON PHARMACEUTICALS INC | 12 May | - |
| ALUNBRIG | BRIGATINIB | TAKEDA PHARMACEUTICALS USA INC | 10 Apr | ODE-300 |
| ARIKAYCE KIT | AMIKACIN SULFATE | INSMED INC | 18 Jan | GAIN |
| ARISTADA | ARIPIPRAZOLE LAUROXIL | ALKERMES INC | 06 Apr | - |
| AUBAGIO | TERIFLUNOMIDE | SANOFI AVENTIS US LLC | 04 Feb | - |
| AUBAGIO | TERIFLUNOMIDE | SANOFI AVENTIS US LLC | 04 Aug | - |
| AUSTEDO | DEUTETRABENAZINE | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC | 18 Mar | - |
| AUSTEDO XR | DEUTETRABENAZINE | TEVA NEUROSCIENCE INC | 18 Mar | - |
| AUVELITY | BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | AXSOME THERAPEUTICS INC | 05 Nov | I-913 |
| AYVAKIT | AVAPRITINIB | BLUEPRINT MEDICINES CORP | 15 Oct | ODE-434 |
| BARHEMSYS | AMISULPRIDE | LXO IRELAND DESIGNATED ACTIVITY CO | 26 Feb | - |
| BAXDELA | DELAFLOXACIN MEGLUMINE | MELINTA SUBSIDIARY CORP | 14 Mar | GAIN |
| BAXDELA | DELAFLOXACIN MEGLUMINE | MELINTA SUBSIDIARY CORP | 02 Jun | GAIN |
| BOSULIF | BOSUTINIB MONOHYDRATE | PF PRISM CV | 28 Feb | PED |
| BOSULIF | BOSUTINIB MONOHYDRATE | PF PRISM CV | 28 Aug | PED |
| BRUKINSA | ZANUBRUTINIB | BEONE MEDICINES USA INC | 22 Apr | ODE* |
| BYFAVO | REMIMAZOLAM BESYLATE | ACACIA PHARMA LTD | 13 Jan | - |
| BYLVAY | ODEVIXIBAT | IPSEN BIOPHARMACEUTICALS INC | 18 Mar | ODE-436 |
| CAMZYOS | MAVACAMTEN | BRISTOL MYERS SQUIBB CO | 19 Jun | ODE-398 |
| CAPLYTA | LUMATEPERONE TOSYLATE | INTRA-CELLULAR THERAPIES INC | 03 Dec | M-319 |
| CIBINQO | ABROCITINIB | PFIZER INC | 19 Feb | NCE |
| CLENPIQ | CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE | FERRING PHARMACEUTICALS INC | 23 Jun | - |
| CLENPIQ | CITRIC ACID; MAGNESIUM OXIDE; SODIUM PICOSULFATE | FERRING PHARMACEUTICALS INC | 26 Jun | - |
| CONTEPO | FOSFOMYCIN DISODIUM | MEITHEAL PHARMACEUTICALS INC | 12 Oct | GAIN |
| CONTEPO | FOSFOMYCIN DISODIUM | MEITHEAL PHARMACEUTICALS INC | 27 Oct | GAIN |
| CONTRAVE | BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 02 Jul | - |
| COSELA | TRILACICLIB DIHYDROCHLORIDE | PHARMACOSMOS AS | 14 Mar | NCE |
| COSELA | TRILACICLIB DIHYDROCHLORIDE | PHARMACOSMOS AS | 30 Dec | NCE |
| COTELLIC | COBIMETINIB FUMARATE | GENENTECH INC | 22 Jun | ODE-416 |
| COTELLIC | COBIMETINIB FUMARATE | GENENTECH INC | 22 Dec | ODE-416 |
| CREXONT | CARBIDOPA; LEVODOPA | IMPAX LABORATORIES LLC | 07 Oct | NP |
| DAWNZERA (AUTOINJECTOR) | DONIDALORSEN SODIUM | IONIS PHARMACEUTICALS INC | 01 May | ODE-550 |
| DAWNZERA (AUTOINJECTOR) | DONIDALORSEN SODIUM | IONIS PHARMACEUTICALS INC | 28 Aug | ODE-550 |
| DEXYCU KIT | DEXAMETHASONE | EYEPOINT PHARMACEUTICALS INC | 23 May | - |
| DEXYCU KIT | DEXAMETHASONE | EYEPOINT PHARMACEUTICALS INC | 22 Jun | - |
| DIFICID | FIDAXOMICIN | CUBIST PHARMACEUTICALS LLC | 28 May | ODE-367 |
| DIFICID | FIDAXOMICIN | CUBIST PHARMACEUTICALS LLC | 28 Nov | ODE-367 |
| DILAUDID | HYDROMORPHONE HYDROCHLORIDE | FRESENIUS KABI USA LLC | 12 Mar | - |
| DILAUDID-HP | HYDROMORPHONE HYDROCHLORIDE | FRESENIUS KABI USA LLC | 12 Mar | - |
| DOJOLVI | TRIHEPTANOIN | ULTRAGENYX PHARMACEUTICAL INC | 14 Nov | ODE-311 |
| DORYX MPC | DOXYCYCLINE HYCLATE | MAYNE PHARMA INTERNATIONAL PTY LTD | 23 Oct | - |
| DORYX MPC | DOXYCYCLINE HYCLATE | MAYNE PHARMA INTERNATIONAL PTY LTD | 23 Dec | - |
| DURYSTA | BIMATOPROST | ABBVIE INC | 31 Oct | - |
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | GILEAD SCIENCES INC | 30 Jan | PED |
| EPCLUSA | SOFOSBUVIR; VELPATASVIR | GILEAD SCIENCES INC | 30 Jul | PED |
| EVOMELA | MELPHALAN HYDROCHLORIDE | ACROTECH BIOPHARMA INC | 30 Jan | - |
| EVZIO | NALOXONE HYDROCHLORIDE | KALEO INC | 18 Jul | - |
| EVZIO (AUTOINJECTOR) | NALOXONE HYDROCHLORIDE | KALEO INC | 18 Jul | - |
| EXBLIFEP | CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM | ORCHID PHARMA LTD | 07 Nov | GAIN |
| EXONDYS 51 | ETEPLIRSEN | SAREPTA THERAPEUTICS INC | 14 Mar | - |
| FABHALTA | IPTACOPAN HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 14 Jul | ODE-524 |
| FIRDAPSE | AMIFAMPRIDINE PHOSPHATE | CATALYST PHARMACEUTICALS INC | 26 May | ODE-553 |
| FORZINITY | ELAMIPRETIDE HYDROCHLORIDE | STEALTH BIOTHERAPEUTICS INC | 28 Feb | ODE-551 |
| FULVESTRANT | FULVESTRANT | FRESENIUS KABI USA LLC | 14 Feb | - |
| FULVESTRANT | FULVESTRANT | FRESENIUS KABI USA LLC | 17 May | - |
| FUROSCIX | FUROSEMIDE | SCPHARMACEUTICALS INC A WHOLLY OWNED SUB OF MANNKIND CORP | 03 Apr | - |
| GANZYK-RTU | GANCICLOVIR | EXELA PHARMA SCIENCES LLC | 02 Sept | - |
| GEMTESA | VIBEGRON | SUMITOMO PHARMA AMERICA INC | 12 Mar | I-955 |
| GEMTESA | VIBEGRON | SUMITOMO PHARMA AMERICA INC | 23 Dec | I-955 |
| GIAPREZA | ANGIOTENSIN II ACETATE | LA JOLLA PHARMA LLC | 18 Dec | - |
| GIVLAARI | GIVOSIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 03 Oct | ODE-273 |
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | BOEHRINGER INGELHEIM | 03 Apr | - |
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | BOEHRINGER INGELHEIM | 11 Jun | - |
| GLYXAMBI | EMPAGLIFLOZIN; LINAGLIPTIN | BOEHRINGER INGELHEIM | 03 Oct | - |
| GOCOVRI | AMANTADINE HYDROCHLORIDE | SUPERNUS PHARMACEUTICALS INC | 17 Jun | - |
| GOCOVRI | AMANTADINE HYDROCHLORIDE | SUPERNUS PHARMACEUTICALS INC | 04 Dec | - |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 30 Jan | ODE* |
| HARVONI | LEDIPASVIR; SOFOSBUVIR | GILEAD SCIENCES INC | 30 Jul | ODE* |
| HEPZATO | MELPHALAN HYDROCHLORIDE | DELCATH SYSTEMS INC | 07 Feb | ODE-438 |
| HEPZATO | MELPHALAN HYDROCHLORIDE | DELCATH SYSTEMS INC | 17 Sept | ODE-438 |
| HETLIOZ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 17 May | ODE-330 |
| HETLIOZ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 10 Oct | ODE-330 |
| HETLIOZ LQ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 17 May | ODE-329 |
| HETLIOZ LQ | TASIMELTEON | VANDA PHARMACEUTICALS INC | 10 Oct | ODE-329 |
| IBRANCE | PALBOCICLIB | PFIZER INC | 08 Feb | I-995 |
| IBRANCE | PALBOCICLIB | PFIZER INC | 08 Aug | I-995 |
| IDHIFA | ENASIDENIB MESYLATE | BRISTOL MYERS SQUIBB | 01 Aug | - |
| IDHIFA | ENASIDENIB MESYLATE | BRISTOL MYERS SQUIBB | 16 Sept | - |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 18 Feb | PED |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 30 Apr | PED |
| IMBRUVICA | IBRUTINIB | PHARMACYCLICS LLC | 24 Oct | PED |
| IMCIVREE | SETMELANOTIDE ACETATE | RHYTHM PHARMACEUTICALS INC | 04 Jul | ODE-508 |
| IMVEXXY | ESTRADIOL | MAYNE PHARMA LLC | 02 Feb | - |
| INLEXZO | GEMCITABINE HYDROCHLORIDE | JANSSEN BIOTECH INC | 19 Aug | NP |
| IZERVAY | AVACINCAPTAD PEGOL SODIUM | ASTELLAS PHARMA US INC | 11 Jul | - |
| JADENU | DEFERASIROX | NOVARTIS PHARMACEUTICALS CORP | 21 Nov | - |
| JAKAFI XR | RUXOLITINIB PHOSPHATE | INCYTE CORP | 17 Jan | PED |
| JAKAFI XR | RUXOLITINIB PHOSPHATE | INCYTE CORP | 14 May | PED |
| JAKAFI XR | RUXOLITINIB PHOSPHATE | INCYTE CORP | 17 Jul | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Apr | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 17 May | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Jun | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Oct | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 17 Nov | PED |
| JARDIANCE | EMPAGLIFLOZIN | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Dec | PED |
| JASCAYD | NERANDOMILAST | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 19 Feb | ODE-546 |
| JUBLIA | EFINACONAZOLE | BAUSCH HEALTH AMERICAS INC | 02 Oct | - |
| JYLAMVO | METHOTREXATE | SHORLA PHARMA LTD | 29 Oct | - |
| KISQALI | RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 07 Aug | PED |
| KISQALI FEMARA CO-PACK (COPACKAGED) | LETROZOLE; RIBOCICLIB SUCCINATE | NOVARTIS PHARMACEUTICALS CORP | 07 Aug | PED |
| KLOXXADO | NALOXONE HYDROCHLORIDE | HIKMA PHARMACEUTICALS USA INC | 26 Aug | - |
| LEQVIO | INCLISIRAN SODIUM | NOVARTIS PHARMACEUTICALS CORP | 18 Aug | ODE-555 |
| LILETTA | LEVONORGESTREL | MEDICINES360 | 22 Mar | I-917 |
| LINZESS | LINACLOTIDE | ABBVIE INC | 16 Feb | PED |
| LITFULO | RITLECITINIB TOSYLATE | PFIZER INC | 03 Dec | NCE |
| LODOCO | COLCHICINE | AGEPHA PHARMA FZ LLC | 09 May | - |
| LONSURF | TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE | TAIHO ONCOLOGY INC | 17 Jun | ODE-229 |
| LONSURF | TIPIRACIL HYDROCHLORIDE; TRIFLURIDINE | TAIHO ONCOLOGY INC | 05 Sept | ODE-229 |
| LOREEV XR | LORAZEPAM | ALMATICA PHARMA LLC | 08 Jan | - |
| LUMISIGHT | PEGULICIANINE ACETATE | LUMICELL INC | 14 Sept | NCE |
| LUZU | LULICONAZOLE | BAUSCH HEALTH US LLC | 28 Apr | - |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 14 Mar | PED |
| MAVYRET | GLECAPREVIR; PIBRENTASVIR | ABBVIE INC | 14 Sept | PED |
| MEKINIST | TRAMETINIB DIMETHYL SULFOXIDE | NOVARTIS PHARMACEUTICALS CORP | 28 Feb | PED |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 24 Feb | NP |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 22 Mar | NP |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 28 Apr | NP |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 13 Jun | NP |
| MIUDELLA | COPPER | SEBELA WOMENS HEALTH INC | 16 Aug | NP |
| MODEYSO | DORDAVIPRONE HYDROCHLORIDE | CHIMERIX INC | 26 Jul | ODE-547 |
| MORPHINE SULFATE | MORPHINE SULFATE | FRESENIUS KABI USA LLC | 12 Mar | - |
| NATESTO | TESTOSTERONE | ACERUS PHARMACEUTICALS CORP | 17 Mar | - |
| NURTEC ODT | RIMEGEPANT SULFATE | PFIZER INC | 27 Feb | - |
| NUZOLVENCE | ZOLIFLODACIN | ENTASIS THERAPEUTICS INC | 21 Jan | GAIN |
| OMIDRIA | KETOROLAC TROMETHAMINE; PHENYLEPHRINE HYDROCHLORIDE | RAYNER SURGICAL INC | 23 Apr | - |
| ONZETRA XSAIL | SUMATRIPTAN SUCCINATE | AZURITY PHARMACEUTICALS INC | 20 Oct | - |
| ORIAHNN (COPACKAGED) | ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM | ABBVIE INC | 14 Mar | - |
| ORILISSA | ELAGOLIX SODIUM | ABBVIE INC | 14 Mar | - |
| ORSERDU | ELACESTRANT HYDROCHLORIDE | STEMLINE THERAPEUTICS INC | 10 Oct | NCE |
| OTEZLA | APREMILAST | AMGEN INC | 29 May | PED |
| OTEZLA | APREMILAST | AMGEN INC | 30 May | PED |
| OTEZLA | APREMILAST | AMGEN INC | 29 Nov | PED |
| OTEZLA XR | APREMILAST | AMGEN INC | 29 May | PED |
| OXBRYTA | VOXELOTOR | GLOBAL BLOOD THERAPEUTICS INC | 29 Jan | ODE-394 |
| OXLUMO | LUMASIRAN SODIUM | ALNYLAM PHARMACEUTICALS INC | 26 Dec | ODE-415 |
| OZEMPIC | SEMAGLUTIDE | NOVO NORDISK INC | 02 May | I-976 |
| PARSABIV | ETELCALCETIDE | KAI PHARMACEUTICALS INC A WHOLLY OWNED SUBSIDIARY OF AMGEN INC | 27 Jun | - |
| PEMAZYRE | PEMIGATINIB | INCYTE CORP | 17 Apr | ODE-404 |
| PROCYSBI | CYSTEAMINE BITARTRATE | HORIZON THERAPEUTICS USA INC | 17 Jun | - |
| PROCYSBI | CYSTEAMINE BITARTRATE | HORIZON THERAPEUTICS USA INC | 17 Dec | - |
| QINLOCK | RIPRETINIB | DECIPHERA PHARMACEUTICALS LLC | 15 May | ODE-298 |
| QUVIVIQ | DARIDOREXANT HYDROCHLORIDE | IDORSIA PHARMACEUTICALS LTD | 02 Dec | M-200 |
| RAPIBLYK | LANDIOLOL HYDROCHLORIDE | AOP HEALTH US LLC | 25 Apr | NCE |
| RAYALDEE | CALCIFEDIOL | EIRGEN PHARMA LTD | 14 Mar | - |
| REZUROCK | BELUMOSUDIL MESYLATE | KADMON PHARMACEUTICALS LLC | 20 Jun | ODE-362 |
| RHAPSIDO | REMIBRUTINIB | NOVARTIS PHARMACEUTICALS CORP | 13 Nov | NCE |
| RHOPRESSA | NETARSUDIL MESYLATE | ALCON LABORATORIES INC | 14 Mar | - |
| RIZAFILM | RIZATRIPTAN BENZOATE | GENSCO LABORATORIES LLC DBA GENSCO PHARMA | 30 Jul | - |
| ROCKLATAN | LATANOPROST; NETARSUDIL DIMESYLATE | ALCON LABORATORIES INC | 14 Mar | - |
| ROMVIMZA | VIMSELTINIB | DECIPHERA PHARMACEUTICALS LLC | 14 Mar | NCE |
| RYALTRIS | MOMETASONE FUROATE; OLOPATADINE HYDROCHLORIDE | GLENMARK SPECIALTY SA | 04 Sept | NPP |
| RYBELSUS | SEMAGLUTIDE | NOVO NORDISK INC | 02 May | I-976 |
| RYZUMVI | PHENTOLAMINE MESYLATE | FAMYGEN LIFE SCIENCES INC | 31 Jan | NP |
| SINUVA | MOMETASONE FUROATE | INTERSECT ENT INC | 13 Mar | - |
| SINUVA | MOMETASONE FUROATE | INTERSECT ENT INC | 24 Nov | - |
| SOFDRA | SOFPIRONIUM BROMIDE | BOTANIX SB INC | 14 Mar | NCE |
| SOFDRA | SOFPIRONIUM BROMIDE | BOTANIX SB INC | 22 May | NCE |
| SOOLANTRA | IVERMECTIN | GALDERMA LABORATORIES LP | 13 Mar | - |
| SOTYLIZE | SOTALOL HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 01 Apr | - |
| SOTYLIZE | SOTALOL HYDROCHLORIDE | AZURITY PHARMACEUTICALS INC | 19 Nov | - |
| SPINRAZA | NUSINERSEN SODIUM | BIOGEN INC | 09 Jan | - |
| SPRAVATO | ESKETAMINE HYDROCHLORIDE | JANSSEN PHARMACEUTICALS INC | 14 Mar | I-959 |
| SPRITAM | LEVETIRACETAM | APRECIA PHARMACEUTICALS LLC | 14 Mar | - |
| SUNLENCA | LENACAPAVIR SODIUM | GILEAD SCIENCES INC | 28 Feb | NCE |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Apr | PED |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 17 May | PED |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Oct | PED |
| SYNJARDY | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 17 Nov | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Apr | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 17 May | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Jun | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Oct | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 17 Nov | PED |
| SYNJARDY XR | EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Dec | PED |
| TAFINLAR | DABRAFENIB MESYLATE | NOVARTIS PHARMACEUTICALS CORP | 28 Feb | PED |
| TALICIA | AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN | TALICIA HOLDINGS INC | 12 Feb | GAIN |
| TAVNEOS | AVACOPAN | CHEMOCENTRYX INC | 06 Jan | ODE-377 |
| TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | EPIZYME INC | 23 Jan | ODE-314 |
| TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | EPIZYME INC | 12 Jun | ODE-314 |
| TAZVERIK | TAZEMETOSTAT HYDROBROMIDE | EPIZYME INC | 22 Aug | ODE-314 |
| TEMBEXA | BRINCIDOFOVIR | EMERGENT BIODEFENSE OPERATIONS LANSING INC | 30 Jul | ODE-354 |
| TEMBEXA | BRINCIDOFOVIR | EMERGENT BIODEFENSE OPERATIONS LANSING INC | 10 Oct | ODE-354 |
| TONMYA | CYCLOBENZAPRINE HYDROCHLORIDE | TONIX PHARMACEUTICALS INC | 14 Mar | NP |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Apr | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Jun | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 03 Oct | - |
| TRIJARDY XR | EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE | BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 11 Dec | - |
| TRIMBOW | BECLOMETHASONE DIPROPIONATE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | CHIESI FARMACEUTICI SPA | 23 Dec | NP |
| TRULANCE | PLECANATIDE | SALIX PHARMACEUTICALS INC | 05 Jun | - |
| TRUSELTIQ | INFIGRATINIB PHOSPHATE | HELSINN HEALTHCARE SA | 11 Dec | ODE-353 |
| TRYNGOLZA (AUTOINJECTOR) | OLEZARSEN SODIUM | IONIS PHARMACEUTICALS INC | 14 Feb | ODE-515 |
| TRYNGOLZA (AUTOINJECTOR) | OLEZARSEN SODIUM | IONIS PHARMACEUTICALS INC | 01 May | NS |
| TUKYSA | TUCATINIB | SEAGEN INC | 17 Apr | ODE-422 |
| VAFSEO | VADADUSTAT | AKEBIA THERAPEUTICS INC | 04 Jun | NCE |
| VAFSEO | VADADUSTAT | AKEBIA THERAPEUTICS INC | 09 Jun | NCE |
| VAFSEO | VADADUSTAT | AKEBIA THERAPEUTICS INC | 14 Nov | NCE |
| VANRAFIA | ATRASENTAN HYDROCHLORIDE | NOVARTIS PHARMACEUTICALS CORP | 07 Jul | NCE |
| VELPHORO | FERRIC OXYHYDROXIDE | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE | 26 Nov | PED |
| VEOZAH | FEZOLINETANT | ASTELLAS PHARMA US INC | 28 Mar | NCE |
| VILTEPSO | VILTOLARSEN | NIPPON SHINYAKU CO LTD | 03 Apr | ODE-280 |
| VIZZ | ACECLIDINE HYDROCHLORIDE | LENZ THERAPEUTICS INC | 24 Mar | NCE |
| VOGELXO | TESTOSTERONE | UPSHER SMITH LABORATORIES LLC | 11 Feb | - |
| VORANIGO | VORASIDENIB | SERVIER PHARMACEUTICALS LLC | 11 Jul | ODE-491 |
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | GILEAD SCIENCES INC | 30 Jan | - |
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | GILEAD SCIENCES INC | 17 Jul | - |
| VOSEVI | SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR | GILEAD SCIENCES INC | 30 Jul | - |
| WAINUA | EPLONTERSEN SODIUM | ASTRAZENECA AB | 01 May | - |
| WAINUA | EPLONTERSEN SODIUM | ASTRAZENECA AB | 25 Aug | - |
| WAINUA (AUTOINJECTOR) | EPLONTERSEN SODIUM | ASTRAZENECA AB | 01 May | ODE-461 |
| WAINUA (AUTOINJECTOR) | EPLONTERSEN SODIUM | ASTRAZENECA AB | 25 Aug | ODE-461 |
| WEGOVY | SEMAGLUTIDE | NOVO NORDISK INC | 02 May | NP |
| WELIREG | BELZUTIFAN | MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC | 05 Sept | I-994 |
| XARELTO | RIVAROXABAN | JANSSEN PHARMACEUTICALS INC | 17 Feb | - |
| XARELTO | RIVAROXABAN | JANSSEN PHARMACEUTICALS INC | 17 Aug | - |
| XEGLYZE | ABAMETAPIR | LNHC INC | 17 Dec | - |
| XELJANZ XR | TOFACITINIB CITRATE | PFIZER INC | 14 Mar | - |
| XELJANZ XR | TOFACITINIB CITRATE | PFIZER INC | 14 Sept | - |
| XELSTRYM | DEXTROAMPHETAMINE | NOVEN PHARMACEUTICALS INC | 12 Mar | - |
| XIPERE | TRIAMCINOLONE ACETONIDE | BAUSCH AND LOMB INC | 02 May | - |
| XPHOZAH | TENAPANOR HYDROCHLORIDE | ARDELYX INC | 10 Apr | NP |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 11 Feb | - |
| XYOSTED (AUTOINJECTOR) | TESTOSTERONE ENANTHATE | ANTARES PHARMA INC | 07 Oct | - |
| YEZTUGO | LENACAPAVIR SODIUM | GILEAD SCIENCES INC | 28 Feb | NP |
| YONSA | ABIRATERONE ACETATE | SUN PHARMACEUTICAL INDUSTRIES LTD | 17 Mar | - |
| YONSA | ABIRATERONE ACETATE | SUN PHARMACEUTICAL INDUSTRIES LTD | 20 May | - |
| ZAVZPRET | ZAVEGEPANT HYDROCHLORIDE | PFIZER INC | 26 Jun | NCE |
| ZEGALOGUE | DASIGLUCAGON HYDROCHLORIDE | ZEALAND PHARMA US INC | 06 Jan | NPP |
| ZEGALOGUE (AUTOINJECTOR) | DASIGLUCAGON HYDROCHLORIDE | ZEALAND PHARMA US INC | 06 Jan | NPP |
| ZELSUVMI | BERDAZIMER SODIUM | LNHC INC | 27 Feb | NCE |
| ZELSUVMI | BERDAZIMER SODIUM | LNHC INC | 28 Feb | NCE |
| ZELSUVMI | BERDAZIMER SODIUM | LNHC INC | 22 Nov | NCE |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 14 Mar | PED |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 28 May | PED |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 09 Sept | PED |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 14 Sept | PED |
| ZERBAXA | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM | CUBIST PHARMACEUTICALS LLC | 28 Nov | PED |
| ZOHYDRO ER | HYDROCODONE BITARTRATE | RECRO GAINESVILLE LLC | 12 Sept | - |
| ZURAGARD | ISOPROPYL ALCOHOL | ZUREX PHARMA | 20 Dec | - |
| ZURZUVAE | ZURANOLONE | BIOGEN INC | 17 Apr | NCE |
| ZYNRELEF KIT | BUPIVACAINE; MELOXICAM | HERON THERAPEUTICS INC | 13 Mar | I-933 |
Provenance
Source: FDA Orange Book patent and exclusivity files. Rows carrying an exclusivity code have a separate regulatory exclusivity that can outlast the patent shown. Patent expiry alone does not determine when a generic can launch: paediatric extensions, 30-month stays and settlement agreements frequently move the effective date. Delisted patents are excluded.